NCT06906341 2025-10-22Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersCorcept TherapeuticsPhase 2 Recruiting270 enrolled
NCT05753826 2024-02-06Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.Fujian Cancer HospitalPhase 2 Recruiting37 enrolled
NCT04519151 2023-06-08Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian CancerSheba Medical CenterPhase 2 Recruiting24 enrolled